i-STAT PT/APTT

Device Abbott Laboratories
Total Payments
$134,850
Transactions
14
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $134,850 14 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $134,850 14 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Clinical Evaluation of the i-STAT PT/APTT Cartridge for PT in Subjects Receiving Coumarin Therapy Abbott Laboratories $129,850 0
Clinical Evaluation of i-STAT PT plus/aPTT Cartridge for PT and aPTT for the Assessment of Subject Coagulation Time and Coagulation Status Abbott Laboratories $2,500 0
Clinical Evaluation of i-STAT PT plus/aPTT Cartridge for aPTT in Subjects Receiving Heparin Therapy Abbott Laboratories $2,500 0

Top Doctors Receiving Payments for i-STAT PT/APTT

Doctor Specialty Location Total Records
Unknown Detroit, MI $134,850 14

About i-STAT PT/APTT

i-STAT PT/APTT is a device associated with $134,850 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.

Payment data is available from 2019 to 2019. In 2019, $134,850 was paid across 14 transactions to 0 doctors.

The most common payment nature for i-STAT PT/APTT is "Unspecified" ($134,850, 100.0% of total).

i-STAT PT/APTT is associated with 3 research studies, including "Clinical Evaluation of the i-STAT PT/APTT Cartridge for PT in Subjects Receiving Coumarin Therapy" ($129,850).